Alcresta develops novel products that deliver enzymatic solutions to those living with rare diseases.

Senior Director supporting development of autologous cellular therapies for the treatment of severe cardiovascular diseases, severe burns, and cartilage injuries.

Clinical development consulting for the biotech and pharmaceutical industry.

Aegis Creative delivers the most effective Advisory Board and Educational Services to innovative global biopharmaceutical companies, enabling a superior understanding of new medical therapies at all stages of drug development, from research to product maturation.

Consulting company providing program and strategic development for the biotech, pharmaceutical, and device industries; Quality Assurance auditing of clinical study sites, databases, and vendors.Medical writing including manuscripts, protocols, SOPs, CRF design, clinical study reports & regulatory submissions.Clinical data management and monitoring.

Director of clinical development program for novel small molecules for the treatment of pain and inflammation

Translational medicine lead responsible for the translational research and clinical development plans for several novel inflammation targets in preclinical development.

Clinical Lead responsible for clinical development plans and protocols for two compounds in clinical development. Clinical Lead responsible for a study validating an experimental pain model for use in translational research.

Study Manager for Phase III registration studies of pregabalin (Lyrica) for the treatment of chronic pain associated with postherpetic neuralgia and diabetic peripheral neuropathy.Designed, initiated and completed a pivotal Phase III pain study in record time in preparation for an NDA filing.

Study manager for a phase 2 study of pregabalin for the treatment of chronic low back pain. Responsibilities included protocol design and finalization, investigator selection, investigator and site initiation meetings, case report form design, clinical research associate training, and summarization of study efficacy and safety data.Designed and initiated large 30-site Phase II study within three months of joining the pharmaceutical industry. Study results were presented in abstract form at the American Pain Society.

Trained several undergraduates, graduate students, and summer students in molecular biology, protein purification, enzymology, and fluorescence spectroscopy.Conducted research resulting in 17 peer-reviewed publications.Managed all aspects of responsibilities required of a Principal Investigator of an RO1 grant, including staff hiring, review, and management of direct reports.Recipient of Basic Scientist research grant from The University of Michigan Medical School.As part of team teaching, developed and presented lectures and quizzes for "at-risk" students about to enter Medical School.